최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기International journal of pharmaceutics, v.530 no.1/2, 2017년, pp.239 - 248
Sapino, Simona (Università) , Oliaro-Bosso, Simonetta (di Torino, Dipartimento di Scienza e Tecnologia del Farmaco, Via P. Giuria 9, 10125 Turin, Italy) , Zonari, Daniele (Università) , Zattoni, Andrea (di Torino, Dipartimento di Scienza e Tecnologia del Farmaco, Via P. Giuria 9, 10125 Turin, Italy) , Ugazio, Elena (Università)
Abstract The systemic administration of methotrexate (MTX), a commonly used, antineoplastic drug which is also used in cutaneous disorders, is primarily associated with prolonged retention in the body and consequently with side effects. Innovative drug delivery techniques and alternative administra...
Eur. J. Pharm. Sci. Abbaszad Rafi 93 64 2016 10.1016/j.ejps.2016.08.005
Colloids Surf. B: Biointerfaces Alexa 106 135 2013 10.1016/j.colsurfb.2013.01.022 A comparative study on long-term MTX controlled release from intercalated nanocomposites for nanomedicine applications
Int. J. Pharm. Alvarez-Figueroa 215 57 2001 10.1016/S0378-5173(00)00674-8 Transdermal delivery of methotrexate: iontophoretic delivery from hydrogels and passive delivery from microemulsions
Pharmazie Boonen 66 463 2011 Skin penetration of silica microparticles
Expert Rev. Clin. Immunol. Cipriani 10 1519 2014 10.1586/1744666X.2014.962996 Methotrexate: an old new drug in autoimmune disease
Clin. Ther. Cipriani 36 427 2014 10.1016/j.clinthera.2014.01.014 Methotrexate in rheumatoid arthritis: optimizing therapy among different formulations. current and emerging paradigms
J. Rheumatol. Curtis 43 1997 2016 10.3899/jrheum.151212 Adherence and persistence with methotrexate in rheumatoid arthritis: a systematic review
Clin. Chim. Acta Elango 451 329 2015 10.1016/j.cca.2015.10.020 Methotrexate normalized keratinocyte activation cycle by overturning abnormal keratins as well as deregulated inflammatory mediators in psoriatic patients
Colloids Surf. B: Biointerfaces Garg 147 17 2016 10.1016/j.colsurfb.2016.07.046 Effective transdermal delivery of methotrexate through nanostructured lipid carriers in an experimentally induced arthritis model
J. Microsc. Goldstein 256 237 2014 10.1111/jmi.12179 High resolution SEM imaging of gold nanoparticles in cells and tissues
Inflamm. Bowel Dis. Herfarth 22 224 2016 10.1097/MIB.0000000000000589 Use of methotrexate in the treatment of inflammatory bowel diseases
BBA Clin. Hess 3 152 2015 10.1016/j.bbacli.2015.01.006 Cancer metabolism and oxidative stress: insights into carcinogenesis and chemotherapy via the non-dihydrofolate reductase effects of methotrexate
Colloids Surf. B: Biointerfaces Javadzadeh 82 422 2011 10.1016/j.colsurfb.2010.09.015 Enhancing percutaneous delivery of methotrexate using different types of surfactants
Leukemia Res. Kim 36 350 2012 10.1016/j.leukres.2011.07.027 A combination of methotrexate and irradiation promotes cell death in NK/T-cell lymphoma cells via down-regulation of NF-κB signaling
J. Innov. Opt. Health Sci. Lademann 8 1530004 2015 10.1142/S1793545815300049 Hair follicles as a target structure for nanoparticles
Semin. Arthritis Rheum. Li 45 656 2016 10.1016/j.semarthrit.2015.11.004 Subcutaneous administration of methotrexate at high doses makes a better performance in the treatment of rheumatoid arthritis compared with oral administration of methotrexate: a systematic review and meta-analysis
Eur. J. Pharm. Sci. Muhammad 91 251 2016 10.1016/j.ejps.2016.04.029 PEG capped methotrexate silver nanoparticles for efficient anticancer activity and biocompatibility
Int. J. Cancer Pan 139 1864 2016 10.1002/ijc.30214 Concurrent radiotherapy and intrathecal methotrexate for treating leptomeningeal metastasis from solid tumors with adverse prognostic factors: a prospective and single-arm study
Int. J. Pharm. Peruzynska 506 458 2016 10.1016/j.ijpharm.2016.03.041 In vitro and in vivo evaluation of sandwich-like mesoporous silica nanoflakes as promising anticancer drug delivery system
J. Eur. Acad. Dermatol. Venereol. Quist 30 1537 2016 10.1111/jdv.13656 Pharmacokinetic profile of methotrexate in psoriatic skin via the oral or subcutaneous route using dermal microdialysis showing higher methotrexate bioavailability in psoriasis plaques than in non-lesional skin
Trends Biotechnol. Reschiglian 23 475 2005 10.1016/j.tibtech.2005.07.008 Field-flow fractionation and biotechnology
Eur. J. Pharm. Biopharm. Sapino 89 116 2015 10.1016/j.ejpb.2014.11.022 Mesoporous silica as topical nanocarriers for quercetin: characterization and in vitro studies
J. Pharm. Sci. Sekkat 91 2376 2002 10.1002/jps.10220 Biophysical study of porcine ear skin in vitro and its comparison to human skin in vivo
Int. J. Pharm. Ugazio 511 446 2016 10.1016/j.ijpharm.2016.07.024 Thermoresponsive mesoporous silica nanoparticles as a carrier for skin delivery of quercetin
Angew. Chem. Int. Ed. Vallet-Regi 46 7548 2007 10.1002/anie.200604488 2007 Mesoporous materials for drug delivery
Expert Rev. Clin. Immunol. Yelamos 11 553 2015 10.1586/1744666X.2015.1026894 Systemic methotrexate for the treatment of psoriasis
Dermatology Yelamos 229 306 2014 10.1159/000366501 Acute severe methotrexate toxicity in patients with psoriasis: a case series and discussion
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.